P-154 Biomarker utility of circRNAs in multiple myeloma: the exemplary cases of ciRS-7 and circCCT3 as surrogate prognostic molecular biomarkers combined with the R-ISS staging system

Article2024

Exploring the molecular biomarker utility of circCCT3 in multiple myeloma: A favorable prognostic indicator, particularly for R‐ISS II patients

Maria Papatsirou, Christos K. Kontos, Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Diamantis C. Sideris, Despina Fotiou, Christine‐Ivy Liacos, Maria Gavriatopoulou, Efstathios Kastritis, Meletios A Dimopoulos, Andreas Scorilas, Evangelos Terpos

Article2015

Evaluation of the Revised International Staging System (R-ISS) in an Independent Cohort of Unselected Patients with Multiple Myeloma

Efstathios Kastritis, Evangelos Terpos, Maria Gavriatopoulou, Magdalini Migkou, Evangelos Eleutherakis‐Papaiakovou, Dimitriοs Ziogas, Ioannis Panagiotidis, Despina Fotiou, Dimitra Gika, Despoina Kalapanida, Eftychia Kafantari, Μαρία Ρούσσου, Flora Zagouri, Stavroula Giannouli, Athanasios Zomas, Kostas Konstantopoulos, Meletios A Dimopoulos

Article2016

Evaluation of the Revised International Staging System (R-ISS) in an Independent Cohort of Unselected Patients with Multiple Myeloma

Maria Gavriatopoulou, Efstathios Kastritis, Evangelos Terpos, Μαρία Ρούσσου, Magdalini Migkou, Despina Fotiou, Evaggelos Papaiakovou, Dimitriοs Ziogas, Ioannis Panagiotidis, Meletios A Dimopoulos

Article2024

ciRS‐7 circular RNA overexpression in plasma cells is a promising molecular biomarker of unfavorable prognosis in multiple myeloma

Maria Papatsirou, Christos K. Kontos, Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Foteini Theodorakakou, Christine‐Ivy Liacos, Nefeli Mavrianou‐Koutsoukou, Despina Fotiou, Magdalini Migkou, Maria Gavriatopoulou, Efstathios Kastritis, Meletios A Dimopoulos, Andreas Scorilas, Evangelos Terpos

Article2010

The International Scoring System (ISS) for Multiple Myeloma Remains a Robust Prognostic Tool Independently of Patients' Renal Function

Meletios A Dimopoulos, Efstathios Kastritis, Marie‐Christine Kyrtsonis, John Meletis, Eurydiki Michalis, Panagiotis Repoussis, Konstantinos Tsatalas, Michael Michael, Anastasia Pouli, Zafiris Kartasis, Ekaterini Stefanoudaki, Michael Voulgarelis, Sosana Delimpasi, Eirini Katodritou, Argiris Symeonidis, Maria Gavriatopoulou, Efstathios Koulieris, Dimitra Gika, Athanasios Zomas, Paraskevi Roussou, Nikolaos Anagnostopoulos, Theofanis Economopoulos,

Discussion(0)

Related publications

Exploring the molecular biomarker utility of circCCT3 in multiple myeloma: A favorable prognostic indicator, particularly for R‐ISS II patients

Evaluation of the Revised International Staging System (R-ISS) in an Independent Cohort of Unselected Patients with Multiple Myeloma

Evaluation of the Revised International Staging System (R-ISS) in an Independent Cohort of Unselected Patients with Multiple Myeloma

ciRS‐7 circular RNA overexpression in plasma cells is a promising molecular biomarker of unfavorable prognosis in multiple myeloma

The International Scoring System (ISS) for Multiple Myeloma Remains a Robust Prognostic Tool Independently of Patients' Renal Function